Intervention studies have shown that inhibiting IRF3/7-mediated downstream gene expression significantly attenuates IFN-I–related inflammation, thereby alleviating autoimmune pathology in SLE (120). The gene discussed is IRF3; the disease is systemic lupus erythematosus.